Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 6 ( November-December, 2022 ) > List of Articles

Original Article

Study on Cervical Cancer Screening Using Pap Smear and Related Factors among Women in Dhiraj Hospital

Rutik Thorat, Jigna Patel, Aishwarya Mehul Patel, Trupti Jansari

Keywords : Cervical cancer, Papanicolaou smear, Premalignant lesions

Citation Information : Thorat R, Patel J, Patel AM, Jansari T. Study on Cervical Cancer Screening Using Pap Smear and Related Factors among Women in Dhiraj Hospital. J South Asian Feder Obs Gynae 2022; 14 (6):653-657.

DOI: 10.5005/jp-journals-10006-2156

License: CC BY-NC 4.0

Published Online: 31-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Introduction: Cervical cancer is the second most common cancer and the leading cause of death in women in developing countries such as India. Papanicolaou (Pap) smear is the most effective and successful screening to identify cervical non-neoplastic lesions as well as lesions with significant epithelial cell abnormalities. Aim: To evaluate the use of Pap smear for detecting premalignant and malignant lesions of the cervix and their incidence with respect to age, parity, age at marriage, and contraception in order to prevent mortality from cervical cancer. Materials and methods: This is a prospective study conducted from October 2021 to June 2022. In this study, Pap smears were collected from 620 women and processed by routine Pap staining techniques and reported on the basis of the revised Bethesda system (2014). Results: In our study, out of 620 smears, 27 smears were inadequate. Maximum smears were found in the age range of 41–50 years, in multiparous women who married at age of 22–27 years, and the ones who did not use any contraception. Inflammatory smears formed the majority with 365 (58.89%) smears. Other following epithelial cell abnormalities were also found: Premalignant lesions such as atypical squamous cells of undetermined significance (ASCUS) (1.9%), atypical squamous cells, HSIL cannot be excluded (ASCH) (0.6%), low-grade squamous intraepithelial lesion (LSIL) (1.3%), high-grade squamous intraepithelial lesion (HSIL) (0.59%), and malignant lesions such as cervical squamous cell cancer (0.33%) and atypical glandular cells (AGC) (0.09%). Conclusion: Our findings suggest that the incidence of cervical carcinoma can be greatly reduced by using Pap smear examination extensively as it helps not only to analyze the spectrum of cervical lesions but also helps in the early detection of premalignant and malignant lesions of the cervix, thereby reducing the mortality in such patients.

PDF Share
  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–E386. DOI: 10.1002/ijc.29210.
  2. Bruni L, Barrionuevo–Rosas L, Albero G, et al. ICO information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases reports. Available at: Accessed on: 20 March 2015.
  3. Jena A, Bharathi T, Reddy YKSK, et al. Papanicolaou (Pap) test screening of staff members of a tertiary care teaching hospital in south India. J Clin Sci Res 2012;1:174–177.
  4. Bhojani KR, Garg R. Cytopathological study of cervical smears and correlation of findings with risk factors. Int J Biol Med Res 2011;2(3):757–761.
  5. Bhattacharya AB, Agarwal A, Dwivedi AD, et al. Uterine cervical smear patterns in females attending a teaching hospital in rural eastern Uttar Pradesh, India. IOSR J Dent Med Sci 2016;1(15):45–49. DOI: 10.9790/0853-1509024549.
  6. Ansari M, Mehdi G, Arif SH, et al. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: A hospital based study. Diagn Cytopathol 2012;40(11):976–983. DOI: 10.1002/dc.21708.
  7. Patel MM, Pandya AN, Modi J. Cervical Pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. Natl J Community Med 2011;2:49–51.
  8. Padubidri V, Daftary SN. Gynecological diagnosis. In: Howkins and Bourne Shaw's Textbook of Gynecology, 13th edition. Noida: Elsevier India Pvt. Ltd., 2004, p. 77.
  9. Mehta RP, Shah A, Vijapura TY, et al. Patel study of epithelial abnormalities in cervical smear of perimenopausal and postmenopausal women. Int J Sci Res 2013;2(7):326–328.
  10. Dinshaw KA, Shastri SS. Screening for cervical cancer in India. Natl Med J India 2001;14(1):1–3. PMID: 11242690.
  11. Juneja A, Sehgal A, Sharma S, et al. Cervical cancer screening in India: Strategies revisited. Indian J Med Sci 2007;61(1):34–47. PMID: 17197739.
  12. Dutta PK, Upadhyay A, Dutta M, et al. A case–control study of cancer cervix patients attending Command Hospital, Pune. Ind J Cancer 1990;27:101–108. PMID: 2228009.
  13. Caplash N, Sobti RC. Epidemiology of cervical cancer case–control study on north Indian population. Indian J Cancer 1999;36(2–4):179–185. PMID: 10921222.
  14. Prabhakar AK, Menon JR. Age at marriage and cervical cancer incidence. Indian J Cancer 1995;32(2):63–68. PMID: 9136459.
  15. Sandjong TI, Sando Z, Tebeu PM, et al. Evaluation of the management of precancerous lesions of the cervix according to the “see and treat” approach. Health Sci Dis 2015;16(4):1–5. In French.
  16. Suma RK, Yalaburgi KS. Screening of pre cancer and cancer cervix by Pap smear among women in reproductive age group: A community based study. Int J Community Med Public Health 2019;6(1):129–134. DOI: 10.18203/2394-6040.ijcmph20185141.
  17. Srivastava AN, Misra JS, Srivastava S, et al. Cervical cancer screening in rural India: Status and current concepts. Indian J Med Res 2018;148(6):687–696. DOI: 10.4103/ijmr.IJMR_5_17.
  18. Biswas L, Manna B, Maiti P, et al. Sexual risk factors for cervical cancer among rural Indian women: A case–control study. Int J Epidemiol 1997;26(3):491–495. DOI: 10.1093/ije/26.3.491.
  19. Sharma P, Rahi M, Lal P. A community based cervical cancer screening program among women of Delhi using camp approach. Indian J Community Med 2010;35(1):86–88. DOI: 10.4103/0970-0218.62576.
  20. Atreche L. Cervicovaginal smears and precancerous lesions (about 2359 cases). Doctoral thesis in medicine, University Sidi Mohamed Ben Abdellah, Morocco; 2008.
  21. Diallo FB, Camara ND, Diallo Y, et al. Epidemiology and prognosis of cervical cancer: Experience of the Ignace deen gynecology university clinic in Conakry in 10 years (1982–1991). Dakar Méd 1992;37: 199–204.
  22. Yasmin S, Mukherjee A. A cyto–epidemiological study on married women in reproductive age group (15–49 years) regarding reproductive tract infection in a rural community of West Bengal. Indian J Public Health 2010;56(3):204–209. DOI: 10.4103/0019-557X.104233.
  23. Gavrik–Lovrec V, Takac I. Use of various contraceptives and human papillomavirus 16 and 18 infections in women with cervical intraepithelial neoplasia. Int J STD AIDS 2010;21(6):421–427. DOI: 10.1258/ijsa.2010.009580.
  24. Runak AI, Mohamed SSS, Saeed ZH. Prevalence and association of atypical cervical epithelial cell abnormalities with different sociodemographic factors among women attending the maternity teaching hospital in Erbil, Iraq. Diyala J Med 2016;11(2).
  25. Nahet A, Boublenza L, Hassaine H, et al. Retrospective study of evaluating screening activities of precancerous cervical lesions in a southern region of Algiers between 2008 and 2011. Afr Cancer 2015;7:168–172. DOI: 10.1007/s12558-015-0389-2.
  26. Kalyani R, Sharief N, Shariff S. A study of Pap smear in a tertiary hospital in South India. J Cancer Biol Res 2016;4(3):1084.
  27. Bamanikar SA, Baravkar DS, Chandanwale SS, et al. Study of cervical Pap smears in a tertiary hospital. Indian Med Gazette 2014:250–254.
  28. Tejeswini V, Premalatha P. Pap smear examination its utility in various cervical lesions. Indian J Pathol Oncol 2016;3(2):242–246.
  29. Sravani P, Neeraja M, Bhavani C, et al. Spectrum of abnormal epithelial lesions of cervix in a tertiary care teaching hospital in South India. Int J Med Res Rev 2017;5(05):472–477. DOI: 10.17511/ijmrr. 2017.i05.06.
  30. de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 2010;11(11):1048–1056. DOI: 10.1016/S1470-2045(10)70230-8.
  31. Alabbody HH, Lafta IJ, Yaseen SA, et al. Assessment of the healthy women by detection and determination of cells in conventional Pap-stained cervical smear images. Int J Med Res Health Sci 2018;7(6):150–160.
  32. Wright TC Jr. Pathology of HPV infection at the cytologic and histologic levels: Basis for a 2-tiered morphologic classification system. Int J Gynecol Obstetr 2006;94(1):S22–S31. DOI: 10.1016/S0020-7292(07)60005-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.